Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD to launch new adverse event reporting service
Vets should continue reporting to manufacturers before the service launches.
The new service goes live on 20 May 2026.

The Veterinary Medicines Directorate (VMD) is to launch its new service for reporting adverse events associated with animal medicines.

A new digital service will go live on 20 May 2026, replacing the previous reporting tool, which is currently suspended.

The tool will enable veterinary professionals, Suitably Qualified Persons (SQPs) and animal owners to report adverse events directly to the VMD. This could include unexpected or harmful reactions in animals, or cases where the medicine does not work as expected.

It now provides users with additional guidance for creating a high-quality report. It is hoped that this will give the VMD more details from the outset.

The service will also be integrated with existing pharmacovigilance processes, which the VMD says will contribute to more efficient and comprehensive safety oversight.

It will initially be released as a beta version, through which users can provide feedback. This feedback will inform future system improvements.

Before the new portal is launched, veterinary professionals can continue reporting adverse events to the manufacturer of the medication. This company will then have a legal responsibility to share this report with the VMD within 30 days.

This will remain an option once the adverse event reporting portal has been launched.

To report adverse events relating to human medicine or medicine not approved for use in animals, users should email adverse.events@vmd.gov.uk to request a form.

Adverse event reporting is considered important to the VMD, helping the department work with medicine manufacturers to identify and respond to potential safety concerns. The VMD says that every report it receives improves its understanding of how medicines are performing in practice.

Image © Shutterstock.com/wavebreakmedia

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.